Lipoxygenase products of arachidonic acid exert pleiotropic effects in biological systems. Leukotrienes derived from the 5-lipoxygenase pathway are significant regulators of leukocyte trafficking, vascular permeability, smooth muscle tone, and cell growth (reviewed in Ref. 1) . Lipoxins (an acronym of lipoxygenase interaction products) are generated by the sequential action of 5 and 12 or 15 and 5 lipoxygenases, depending on the cellular context (2, 3) . Lipoxins (LX) modulate neutrophil trafficking across endothelia and epithelia (reviewed in Refs. 2 and 4) and promote nonphlogistic phagocytosis of apoptotic neutrophils by macrophages (5) . Therefore, in the context of effects on neutrophil trafficking, LXs act as endogenous "braking signals" in the inflammatory process (2, 4, 5) . LXA 4 1 and LTD 4 have previously been shown to exert counter-regulatory roles on renal mesangial cell function (6 -10) . Mesangial cells are modified smooth muscle cells playing a pivotal role in renal physiology by regulating circulation and glomerular structural integrity. LTD 4 has been implicated in the development of glomerulonephritis triggering mesangial cell contraction, reduced glomerular capillary area, a fall in renal blood flow, a fall in glomerular filtration rate (11) (12) (13) (14) (15) , and mesangial cell proliferation (16) . In contrast to this essentially proinflammatory scenario, LXs inhibit neutrophil recruitment to inflamed renal glomeruli in models of acute glomerulonephritis and attenuate LTD 4 -induced smooth muscle and mesangial cell contractility (7, 8, 17, 18) . Furthermore, LXA 4 modulates LTD 4 -induced decreases in glomerular filtration rate (6) .
Controversy exists as whether these agents act at distinct receptors in target cells (6, 9, 10) or whether LXA 4 antagonizes the cellular and in vivo actions of LTD 4 by competing for a common receptor (6) . [ 3 H]LTD 4 binding to mesangial cells can be competitively displaced by LXA 4 , and LXA 4 can attenuate LTD 4 -induced increases in IP 3 generation, suggesting partial agonism (6) . In neutrophils, monocytes, and intestinal epithelia, cDNA cloning and expression studies indicate that the LXA 4 receptor is a member of the chemokine receptor superfamily (19 -22) , distinct from the leukotriene B 4 receptor (23) and with a high degree of homology to the formylmethionylleucylphenylalanine-like receptor (19) . The myeloid LXA 4 receptor is coupled to phospholipaseA 2 and phospholipase D activation through pertussis toxin-sensitive G proteins (19, 20) .
LTD 4 receptor activation may be coupled to both pertussis toxin-sensitive and pertussis toxin-insensitive G proteins dependent on cell type and differentiation (24) . LTD 4 activation causes a rise in intracellular calcium from both intracellular and extracellular stores (25) (26) (27) (28) . A human cysteinyl leukotriene receptor (cysLT 1 /LTD 4 ) has recently been cloned (29) . This receptor binds LTD 4 with high affinity (K d ϭ 0.3 nM) and is functionally coupled to calcium mobilization upon stimulation with LTC 4 and LTD 4 (29) . In monocytes, LTD 4 stimulation is associated with PKC-␣ translocation and subsequent activation of Raf-1 (30) . Relatively little is known of the cellular signaling pathways elicited by either LTD 4 or LXA 4 in mesangial cells. MAP kinases are a family of serine-threonine kinases activated by a cascade of protein-protein interactions. Activation of MAP kinases is critical to several aspects of mesangial cell function, such as proliferation, cell adhesion, and gene expression (31) . MAP kinase activation subsequent to receptor stimulation has been extensively demonstrated. Tyrosine phosphorylation of growth factor receptors leads to a series of kinase reactions culminating in phosphorylation and activation of MAP kinase (reviewed in Ref. 32 ). More recently, it has become appreciated that receptors coupled to heterotrimeric G proteins can stimulate MAPK activation (reviewed in Ref. 33 ). Based on the sequence specificity of the MAPK tripeptide phosphorylation motif, three families have been identified: extracellular-related signal regulated kinases (erks); p38, a homologue of yeast HOG-1; and c-Jun N-terminal kinases. MAPKs are activated by a family of dual specificity kinases (MAPK kinase or MAPK/erk kinase) subsequent to MAPK/erk kinase kinase activation. Several molecules linking ligand binding to G protein-coupled receptors (GPCRs) to MAP kinase activation have been identified; among these is phosphoinositide 3-kinase (PI 3-kinase) (34, 35) . Activation of the PI 3-kinase family of lipid kinases regulates multiple cell functions, including proliferation.
Here, we present data on proliferative responses to both LTD 4 and LXA 4 in mesangial cells and on activation of members of the MAP kinase superfamily (erk and p38 kinases). These data indicate that LTD 4 -induced proliferation can be blocked by LXA 4 and requires both erk and PI 3-kinase activation. LXA 4 blocked LTD 4 -induced PI 3-kinase activity in parallel to inhibitory effects on mesangial cell proliferation. LXA 4 may cause differential activation of MAP kinases by binding to both a common LTD 4 receptor and a specific LXA 4 Human Mesangial Cell Culture-SV40-transformed human mesangial cells were cultured in RPMI 1640 medium supplemented with 5% fetal calf serum (FCS), penicillin (100 units/ml), and streptomycin (100 g/ml). These cells retain the phenotypic characteristics of mesangial cells, including stellate morphology, typical ␣-actinin expression, and production of extracellular matrix proteins and are negative for cytokeratin and endothelial markers (36, 37) . Cells were grown in six-well plates for determination of MAP kinase activity. Before being treated with the indicated agents, cells were cultured in serum-free medium or media containing 0.5% FCS (24 -48 h) as indicated.
Cell Proliferation Assay-Mesangial cells were plated on 96-well plates (500 cells/well) and cultured in 5.0% FCS for 24 h. Prior to the experiments, cells were incubated for 48 h in serum-free culture medium. Incubation was continued for another 48 h with the indicated agents as detailed in the figure legends. Proliferation of mesangial cells was measured by determination of the number of viable cells using an assay in which a tetrazolium salt is reduced by viable cells to aqueous soluble formazan (Promega) and A 450 nm is determined (38) . The quantity of formazan product as measured by A 450 nm was directly proportional to the number of living cells.
cDNA Library Construction and Receptor Cloning-A mesangial cell cDNA library was constructed using 2 g of total RNA from mesangial cells as a template for SMART PCR cDNA library construction (CLON-TECH). The library was used as template in an amplification reaction with oligonucleotides based on the myeloid LXA 4 receptor. The resulting PCR product was further analyzed by Southern blotting and showed hybridization with a [
32 P]dCTP-labeled internal probe based on the myeloid receptor (data not shown). The library was also used as template in PCRs with oligonucleotides based on the cysLT 1 /LTD 4 receptor (29) . An initial product obtained using sequences spanning the open reading frame was further amplified with internal oligonucleotides. In both cases, the resulting products were subcloned into PCR2.1 (Invitrogen, San Diego, CA) and partially sequenced using the ABI 310 automated sequencer (Perkin-Elmer). Total RNA was extracted from human renal mesangial cells cultivated in 0.5% FCS for 48 h using Trizol reagent (Life Technologies, Inc.). cDNA was produced by reverse transcription. Oligonucleotide sense and antisense primers were constructed from published sequences of myeloid LXA 4 receptor (19), cysLT 1 receptor (29), and glyceraldehyde-3-phosphate dehydrogenase and contained the following sequences: LXA 4 receptor, TTCCGGATGA-CACGCACAGTC (sense) and CCAATTGGTCCTACAGTTA (antisense); LTD 4 receptor, TGCATTGCAATTGTTTTTCC (sense) and AATTGGAT-GCAGCCAGAGAC (antisense); glyceraldehyde-3-phosphate dehydrogenase, ACCACAGTCCATGCCATC (sense) and TCCACCACCCTGTT-GCTG (antisense). A hot start cycle of 72°C (5 min), 4°C (5 min), and 94°C (5 min) preceding addition of Taq polymerase was included in which the library was template. Amplification protocols for LXA 4 receptor consisted of 35 repetitive cycles of denaturing at 94°C (1 min), annealing at 61°C (1 min), and extension at 72°C (1 min 20 s). LTD 4 receptor was amplified by 35 repetitive cycles of denaturing at 94°C (1 min), annealing at 60°C (1 min), and extension at 72°C (1 min 20 s). Primers for glyceraldehyde-3-phosphate dehydrogenase were used as internal controls, as described. Amplification protocols for glyceraldehyde-3-phosphate dehydrogenase consisted of 35 repetitive cycles of denaturing at 94°C (30 s), 64°C (1 min), and 72°C (1 min). Amplified cDNA was separated by agarose gel (1.1%) electrophoresis and visualized with ethidium bromide.
Western Blot Analyses of Phosphorylated MAP kinases-Subconfluent cell cultures were rendered quiescent by serum restriction in 0.5% FCS RPMI 1640 medium for 24 -48 h. After this period, cells were stimulated with various agents for indicated times as detailed in the legends to Figs. 3-8. After washing cells once with ice cold phosphatebuffered saline, lysates were harvested in ice cold hypotonic lysis buffer containing 50 mM Tris, pH 7.5, 150 mM-NaCl, 5% Triton X-100, and protease inhibitors (2 mM phenylmethylsulfonyl fluoride, 1 mg/ml leupeptin, 20 mM ␤-glycerophosphate, 0.5 mM dithiothreitol, and 1 M sodium orthophosphate). The lysates were centrifuged and supernatants processed for immunoblotting as described previously (39) . Protein was assayed in appropriately diluted samples by the method of Bradford. The cell lysates (40 g of protein/well) were resolved on a 10% SDS-polyacrylamide gel before blotting onto polyvinylidene difluoride membranes. Equal loading and transfer of proteins was verified by staining a portion of the membranes with Coomassie Brilliant Blue. Nonspecific sites on the membranes were blocked by incubation in 5% (w/v) nonfat milk TBS. The blots were incubated with primary antibody. Antisera specific for phosphorylated p38 MAPK (Tyr-182) or phosphorylated erk (Thr-202/Tyr-204) were diluted 1:1000 in blocking buffer containing 0.1% Tween-20. After overnight incubation at 4°C, blots were washed with TBS with 0.1% Tween-20 and incubated with an appropriate alkaline phosphatase-conjugated secondary antibody. Specific antibody binding was measured with a colorimetric substrate (4-nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl-phospate). Data were quantitated using the Gelworks and Grabit programs (Ultra-Violet Products).
Erk Activity Assay-Erk activity was measured using myelin basic protein as substrate (40) . Cells were treated with various agents as indicated and phospho-erk immunoprecipitated from 50 g of cell lysate. Kinase activity was determined in 20 mM HEPES, 20 mM MgCl 2 , 20 mM ␤-glycerophosphate, 100 M Na 3 VO 4 , 2 mM dithiothreitol, 20 M ATP, pH 7.7, containing 2.5 Ci of [␥-
32 P]ATP/tube (3000Ci/mmol) and 4 g of myelin basic protein. The phosphorylation reaction proceeded for 20 min at 30°C and was terminated by adding denaturing sample buffer and boiling the samples. Lysates were resolved by SDS-polyacrylamide gel electrophoresis, and phosphorylated substrate was detected by autoradiography.
SAPk Assay-SAPk activity was measured using a solid phase assay with recombinant ATF 2 -GST fusion protein as substrate (41) . Lysates were prepared from cells treated as indicated, and cell lysates were incubated with ATF 2 -GST-conjugated agarose beads.
Protein Kinase C Activity Assay-PKC activity was measured in immunoprecipitates from serum-starved mesangial cells treated with LTD 4 (1 nM), LXA 4 (1 nM), vehicle, or phorbol 12-myristate 13-acetate (100 nM, positive control) using the Promega peptide phosphorylation kit according to the manufacturer's instructions.
Phosphatidylinositol 3-Kinase Activity Assay-PI 3-kinase activity was detected by measuring the level of [␥- 32 P]ATP phosphorylation of a phosphoinositides by the immunoprecipitated kinase (42) . Mesangial cells were cultivated in 100-mm dishes as described above prior to stimulation with various agents for 50 s. Cells were harvested in lysis buffer (10 mM HEPES, 400 mM KCl, 1 mM EDTA, 0.5 mM dithiothreitol, 10% glycerol, 1 mM benzamide, 1 mM phenylmethylsulfonyl fluoride, 1 mM ␤-glycerophosphate at 4°C for 30 min.). Insoluble material was removed by centrifugation at 4°C for 10 min at 10,000 ϫ g. 100 g of protein/sample was incubated with 1 l of anti-PI 3-kinase p85 antibody or preimmune serum overnight at 4°C. Protein A-Sepharose beads (Sigma) were added, and incubation continued for an additional 2 h. Immunoprecipitated PI 3-kinase activity was measured using dispersed phosphoinositide as substrate (final concentration, 0.2 mg ml Ϫ1 ). Identity of products was confirmed by comparison with authentic phospholipid standards. PI 3-kinase activity was defined as LY 294002-sensitive lipid kinase activity. Products were quantified by phosphorimage analysis (Bio-Rad).
Ras Activation Assay-Ras activation was measured using a Raf-1-GST fusion protein that binds GTP-bound, i.e. active, Ras as described previously (43) . In brief, pGEX-KG-Raf-RBD-GST expression was induced with isopropyl-1-thio-␤-D-galactopyranoside, and the fusion protein was isolated from glutathione-Sepharose beads. Mesangial cells were serum deprived for 48 h prior to incubation with indicated ligands. Cell lysates were prepared in 50 mM HEPES, pH 7.4, 10 mM NaF, 75 mM NaCl, 1% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride, 1 mM Na 2 VO 3. Equal quantities of lysate protein (as determined by Bradford assay) were incubated with GST-Raf-RBD-coupled glutathione-agarose beads. Bound protein was dissociated by heating the samples to 95°C. Activated Ras was detected by immunoblotting the denatured, dissociated protein using a pan-Ras antibody (1: 25 dilution). Bound primary antibody was detected using enhanced chemiluminescence. 4 -LTD 4 stimulated proliferation of renal mesangial cells. This response was dose-dependent, with a maximal effect seen at 1 ϫ 10 Ϫ8 M and an EC 50 of approximately 1 ϫ 10 Ϫ9 M. In contrast, LXA 4 (1 ϫ 10 Ϫ12 to 1 ϫ 10 Ϫ6 M) had no significant effect on mesangial cell proliferation. However, the mitogenic effect of LTD 4 (1 ϫ 10 Ϫ9 M) was negated by coincubation of the cells with equimolar LXA 4 ( Fig. 1) . The effects of LXA 4 were apparent at 24 h and maximal at 48 h. The mitogenic effect of LTD 4 was not mimicked by its precursor LTC 4 (data not shown). The involvement of the previously described myeloid LXA 4 receptor in the antiproliferative effect of LXA 4 on LTD 4 -stimulated cells was suggested by our observation that neutralizing antisera (20, 44) to the LXA 4 receptor blocked the antiproliferative effect of LXA 4 ( Fig. 1) . Human Mesangial Cells Express Myeloid LXA 4 Receptor and cysLT 1 /LTD 4 Receptor-The generation of a mesangial cell cDNA library afforded the opportunity to screen for the previously described LXA 4 (19) and cysLT 1 /LTD 4 receptors (29) . To this end, a PCR strategy was adopted that allowed amplification of two independent cDNA fragments that were subcloned and partially sequenced. Subsequent sequence analysis verified the cloning of the corresponding receptors in the mesangial cell exhibiting complete identity at the nucleic acid level (Fig.  2) . We have also used reverse transcription-PCR to analyze expression of the receptors in the transformed human mesangial cell line used in the studies described here. Using primers identical to those used to screen the cDNA libraries, we found expression of both receptor subtypes (data not shown) (details of primer sequences are provided above).
RESULTS

LTD 4 -stimulated Proliferation of Mesangial Cells Is Inhibited by LXA
LXA 4 and LTD 4 Activate erk through Different Mechanisms-Activation of p42-p44 erk was determined by immunoblotting with phospho-erk-specific antibodies. Treatment of mesangial cells with LXA 4 (10 nM) activated erk. This was detectable after 2 min, maximal at 15 min, and sustained at 30 min (Fig. 3a) . In lysates from LTD 4 (10 nM)-stimulated cells, phospho-erk was detectable by 5 min, maximal at 10 -15 min, and approximated basal by 30 min (Fig. 3c) . In vitro phosphorylation of myelin basic protein was used to assay erk activity in lysates from cells stimulated with either eicosanoid (Fig. 3, b  and d) . These data corroborated the kinetics of erk activation seen with phosphospecific antibodies (Fig. 3, a and c) . The dose dependence of erk activation in response to LXA 4 concentrations (Fig. 4) . Densitometric analyses of immunoblots probed with phospho-erk-specific antibodies indicated a maximal effect of LXA 4 at 1 nM (Fig. 4a) and of LTD 4 at 10 nM (Fig. 4b) .
In order to investigate the G proteins through which the mesangial cell LTD 4 and LXA 4 receptors couple, we used pertussis toxin labeling to ADP-ribosylate G i/o containing heterotrimeric G proteins and thereby inhibited dissociation of functional ␣ and ␤␥ subunits. In cells pretreated with PTX (100 ng/ml; 18 h), LTD 4 -induced erk phosphorylation was abolished. In contrast, erk phosphorylation in response to LXA 4 persisted in PTX-treated cells (Fig. 5a) . We compared the relative sensitivities of LTD 4 -and LXA 4 -stimulated erk phosphorylation to the LTD 4 receptor antagonist SKF 104353. This agent has previously been shown to block effects of both eicosanoids on calcium mobilization in rat mesangial cells (6) . Interestingly, we found that whereas LTD 4 -induced erk phosphorylation was inhibited to levels comparable to basal, LXA 4 activation persisted (Fig. 5b) . Pretreatment of mesangial cells with the bisindolylmaleimide PKC inhibitor GF 109203X (10 M) (45) inhibited erk phosphorylation in response to both LTD 4 and LXA 4 ( Fig. 5c) . Involvement of PKC in erk activation was further supported by experiments in which PKC down-regulation by treatment of the cells with phorbol ester (100 nM phorbol 12-myristate 13-acetate, 18 h) inhibited erk phosphorylation (data not shown). Furthermore, both LXA 4 and LTD 4 activated mesangial cell PKC as measured by in vitro peptide phosphorylation assay (Promega) (data not shown). In contrast to the ubiquity of PKC in LTD 4 -and LXA 4 -induced erk activation in response to either agent, the PI 3-kinase inhibitor wortmannin (200 nM) (46) inhibited LTD 4 activation but not LXA 4 activation of erk (Fig. 5d) .
LXA 4 and LTD 4 Activate p38 MAP Kinase-Activation of p38 was investigated by immunoblotting with phosphospecific antibodies. p38 phosphorylation in response to LXA 4 (10 nM) was detectable within 2 min of stimulation (the earliest time point investigated) and was maximal by 10 min and remained elevated at 30 min (Fig. 6a) . LTD 4 (10 nM) also activated p38, although less robustly than LXA 4 (Fig. 6c) . Activity of the SAPks p38 and c-Jun N-terminal kinase was determined by phosphorylation of the recombinant fusion protein ATF 2 -GST. ATF 2 -GST phosphotransferase activity corroborated the phos- pho-p38 immunoblot data (Fig. 6, b and d) . c-Jun N-terminal kinase activation was also investigated using phosphospecific antibodies as described for erk and p38. The data on c-Jun N-terminal kinase activation typically paralleled that seen for p38 (data not shown). The dose dependence of p38 phosphorylation was investigated. These data indicated a maximal effect of LXA 4 and LTD 4 on p38 phosphorylation at 1 nM (Fig. 7) .
To investigate whether LXA 4 or LTD 4 was acting through a common receptor to activate p38, we used the discriminating agents as outlined above (PTX, SKF 104353, GF 109203X, and wortmannin). PTX pretreatment of mesangial cells blocked both LXA 4 -and LTD 4 -stimulated p38 phosphorylation (Fig.  8a) . Exposure of human renal mesangial cells to SKF 1043543 (100 nM) inhibited both LXA 4 and LTD 4 -induced phosphorylation of p38 (Fig. 8b) . GF 109203X also inhibited activation of p38 in response to either agent (Fig. 8c) . The PI 3-kinase inhibitor wortmannin inhibited LTD 4 -stimulated p38 phosphorylation (Fig. 8d) . LTD 4 Activates Mesangial Cell Ras-To further delineate the downstream signaling events subsequent to LTD 4 and LXA 4 stimulation and activation of the MAP kinases, Ras activity was measured. These data indicate that, whereas LTD 4 activates Ras, LXA 4 activation does not (Fig. 9) .
LTD 4 -stimulated Proliferation Is PI 3-kinase-and erk-dependent and Involves PDGF Receptor Transactivation-To investigate whether activation of PI 3-kinase and/or erk was required for the proliferative response to LTD 4 , we investigated the effects of LY 294002 (100 M) (47) and the erk inhibitor PD 98059 (10 M) (48) . Pretreatment of mesangial cells with either of these agents (both for 60 min) blocked LTD 4 -stimulated proliferation (Fig. 10) . Interestingly, inhibition of PDGF-asso- ciated tyrosine kinase activity with AG 1296 (49) blocked LTD 4 -induced mitogenesis, whereas the epidermal growth factor receptor inhibitor AG 1478 (50) was without effect (although it did inhibit epidermal growth factor-induced proliferation; data not shown).
LXA 4 Inhibits LTD 4 Activation of PI 3-Kinase-PI 3-kinase was immunoprecipitated from appropriately treated cells, and lipid kinase activity measured in the presence of [␥-32 P]ATP. LTD 4 activated PI 3-kinase, and a maximal effect was observed at 50 s (time course examined in initial experiments was 15 s to 5 min). The extent of activation was comparable to that seen with PDGF-␤, a positive control (51) used in these experiments. LXA 4 did not modulate PI 3-kinase activity; however, LXA 4 attenuated LTD 4 -induced activation of PI 3-kinase (Fig. 11) .
DISCUSSION
Glomerulonephritis is characterized acutely by leukocyte infiltration and mesangial cell proliferation. Such mesangial cell proliferation is frequently associated with dysregulated matrix production and sclerosis. The resolution of glomerulonephritis is dynamically regulated and involves coordinated suppression of inflammation and promotion of recovery by processes that include the following: dissipation of local gradients of proinflammatory mediators; generation of endogenous braking signals, such as LXs, to inhibit further leukocyte recruitment; restoration of normal glomerular cell number by clearance of recruited leukocytes; and inhibition of mesangial cell proliferation (8) and potential regulation of matrix accumulation (44) .
The functional significance of LTD 4 in renal inflammation is well established (6 -16) . Mesangial cell proliferation in response to paracrine mediators, such as LTD 4 , is a pivotal event in the development of progressive renal injury (52) . In this context, inhibition of leukotriene biosynthesis can blunt the mesangioproliferative response following immune-mediated injury (16) ; furthermore, increased LXA 4 production protects from decrements in glomerular function in models of nephritis in vivo (53) . Of significance in this regard is the potential for transcellular production of mesangial cell LXA 4 from leukocyte LTA 4 (3). Pharmacologic inhibitors of LTD 4 have been shown to preserve glomerular filtration and barrier function in models of glomerulonephritis (12, 15) .
The data presented here expand on the evidence that LXA 4 can act as an inhibitor of LTD 4 bioactions in an additional capacity to its established effects on modulating leukocyte trafficking (4, 5) . We report that LXA 4 (6) . Our data on the activation of the MAP kinases erk and p38 in response to the two eicosanoids indicate the likelihood of expression of at least two LXA 4 receptor subtypes in human renal mesangial cells. These conclusions are supported by the following observations: whereas both LTD 4 and LXA 4 activated erk and p38 MAP kinases, the activation of both kinases in response to LTD 4 was antagonist (SKF 104353)-sensitive, and activation of erk in response to LXA 4 was insensitive. This suggested that LXA 4 might act at both a common LTD 4 and a distinct LXA 4 receptor. Consistent with this hypothesis are our data showing selective sensitivity of LXA 4 activation of the MAP kinases to PTX. P38 activation is PTXsensitive, whereas erk activation is insensitive. In contrast, LTD 4 activation of both erk and p38 is PTX-sensitive.
Screening of the mesangial cell cDNA library verified expression of previously described LTD 4 and LXA 4 receptors. We propose that LXA 4 activates erk through two distinct receptors. One receptor is PTX-insensitive and may be coupled to PKC and downstream erk activation through G q family members (G q , G 12 , G 16 , and G z ). Stimulation of this receptor by LXA 4 results in sustained erk activation relative to the acute activation seen with LTD 4 . Such sustained activation is associated with extraproliferative effects of erk, such as expression of cdk inhibitor protein and inhibition of DNA synthesis (54) . A second common LTD 4 -LXA 4 receptor (SKF 104353-sensitive) is coupled to PI 3-kinase, erk, and p38 activation via ␤␥ subunit release from G i␣ . Mesangial cells express PLC␤ 1 and PLC␤ 3 isoforms (37), which show differential sensitivity to activation by ␤␥ subunits (55). It is possible that the LXA 4 -specific receptor activates PLC␤ 1 and PLC␤ 3 , whereas LXA 4 and LTD 4 work through a common receptor to activate PLC␤ 3 . PI 3-kinase is known to activate MAP kinases through multiple mechanisms, including activation of calcium-independent PKC, Akt/PKB and p70 s6 kinase. We have found that the PI 3-kinase inhibitor wortmannin blocked erk and p38 activation in response to LTD 4 (Fig. 7) (LY 294002 was also found to be inhibitory; data not shown). LXA 4 -stimulated p38 and erk activities were differentially compromised by these agents; erk activity was relatively insensitive. These data suggested that LTD 4 activation of erk and p38 might be downstream of PI 3-kinase activation. Direct assay of PI 3-kinase activity indicated that LTD 4 activation of PI 3-kinase was blocked by SKF 104353 (data not shown). The degree of activation in response to LTD 4 was comparable to that seen with PDGF-␤, a potent mitogen known to activate mesangial cell PI 3-kinase (51, 56) . LXA 4 did not activate PI 3-kinase; furthermore, co-stimulation of the cells with both LXA 4 and LTD 4 blunted the stimulation seen with LTD 4 alone. An essential role for both PI 3-kinase and erk activation in LTD 4 -induced mesangial cell proliferation was suggested by its sensitivity to both LY 294002 and PD 98059 and the fact that LXA 4 activated erk but not PI 3-kinase and did not stimulate proliferation. Analogous requirements for both PI 3-kinase and erk activation in lysophosphatidic acid-induced renal epithelial cell proliferation and in PDGFstimulated mesangial cell proliferation have recently been reported (56, 57) . In addition, receptor tyrosine kinases have been shown to be transactivated by GPCRs. (58, 59) . Such transactivation typically involves ligand-independent activation of receptor tyrosine kinases subsequent to activation of GPCRs. Recently, two groups have demonstrated a role for growth factor receptor transactivation in the context of bradykinin-and lysophosphatidic acid-stimulated PI 3-kinase (60, 61) . We propose LTD 4 transactivates the PDGF receptor in mesangial cells as the specific inhibitor of the PDGF receptor, AG 1296, inhibited LTD 4 -induced proliferation. The mechanisms of LXA 4 -inhibition of PI 3-kinase activity and mesangial cell proliferation are currently under investigation and may involve phosphatase activation analogous to the inhibitory effects of somatostatin on insulin-induced mitogenesis mediated through the SST-2 GPCR subtype (62) . Transcellular generation of 15-epi-LXs by neutrophil-adenocarcinoma cell (A549) coincubations have been shown to inhibit A549 cell proliferation by an unknown mechanism (63) .
In summary, these data demonstrate expression of previously described LXA 4 and LTD 4 receptors in renal mesangial cells. These receptors are coupled to activation of MAP kinases. LTD 4 -stimulated mesangial cell proliferation was dependent on erk and PI 3-kinase activity and involves PDGF-␤ receptor transactivation. LXA 4 inhibited LTD 4 -induced proliferation. These data further expand on the anti-inflammatory repertoire of lipoxins.
